Jack hier✌️Raketetoni, it's your turn. 🫵 In recent weeks and months, I've dissected several stocks from the community down to the bone and sent half the watchlist to the crematorium. Today your micro-cap gamble (?) gets to feel my scythe. 💀
🎯 The hot niche on the AI flatland
inTEST Corporation does not operate as a dazzling AI software hype, but as a tangible workbench for the semiconductor infrastructure. The company builds physical, highly complex test and temperature management systems (ThermoSpot, Temptronic). The logic behind this: The more brutally modern data centers and AI chips run under full load (sometimes 700 to over 1000 watts per GPU), the more extreme the heat development becomes. Without the thermal equipment from inTEST, the hardware simply burns out during the stress test before delivery. A classic shovel-and-pick play at the lower end of the food chain.
🛠️ DNA check & transformation
The operating lever kicks in: The past Q1/2026 shows a brutal turnaround. Organic sales growth shot up by +27.2% YoY.
Earnings explosion: Adjusted non-GAAP EPS came in at USD 0.16, pulverizing the fearful analyst consensus (USD 0.09) by a whopping +78%.
Solid balance sheet: No toxic micro-cap debt. With a net debt/EBITDA of ~0.9x and quick/current ratios comfortably above 2.0, the growth phase is fully financed.
Full pipeline: The order backlog was over USD 51 million as at the end of March 2026 - this ensures planning reliability for the coming quarters.
🚀 Growth levers & catalysts:
The Rogoff effect: new CEO Rich Rogoff has been at the helm since April 2026 and delivered straight away at his debut. He has ice-coldly raised the annual forecast for 2026 to USD 130 to 135 million.
Wall Street is waking up: Analysts had to revise their historically depressed share price targets mechanically upwards from USD 10 towards USD 19.30 to USD 20.00 after the Q1 blowout.
Industry diversification: inTEST protects itself from the pure semiconductor hog cycle by aggressively expanding into the thermal test markets of defense/aerospace and medical technology.
⚠️ Valuation & Risks:
The micro-cap whipsaw: with a tiny market capitalization of ~$230m, extreme price volatility and liquidity constraints are commonplace.
Increased working capital requirements: Brutal growth eats up cash. The cash conversion cycle is damn slow at over 100 days because high inventories have to be pre-financed.
The cluster risk: If giants such as Nvidia or AMD consolidate their testing with the industry's billion-dollar giants (Teradyne, Cohu), inTEST will be pushed out of its niche with a cold head.
My conclusion for you: INTT
"Raketentoni, you haven't told a complete fairy tale this time - the Q1 figures prove that the operating leverage at inTEST has just kicked in massively. At a forward P/E of around 18.4x, the speculative growth is absolutely affordable for an AI infrastructure profiteer. But don't make the mistake of confusing this thing with an indestructible moat compounder. It remains a highly cyclical micro-cap gamble for the risk-averse portfolio corner. If you are disciplined and wait for setbacks, you will catch an asymmetrical setup."
Status: 🟢 BUY (as a speculative satellite addition)
Reaper Score: 6/10
🎯 The hot niche on the AI flatland
inTEST Corporation does not operate as a dazzling AI software hype, but as a tangible workbench for the semiconductor infrastructure. The company builds physical, highly complex test and temperature management systems (ThermoSpot, Temptronic). The logic behind this: The more brutally modern data centers and AI chips run under full load (sometimes 700 to over 1000 watts per GPU), the more extreme the heat development becomes. Without the thermal equipment from inTEST, the hardware simply burns out during the stress test before delivery. A classic shovel-and-pick play at the lower end of the food chain.
🛠️ DNA check & transformation
The operating lever kicks in: The past Q1/2026 shows a brutal turnaround. Organic sales growth shot up by +27.2% YoY.
Earnings explosion: Adjusted non-GAAP EPS came in at USD 0.16, pulverizing the fearful analyst consensus (USD 0.09) by a whopping +78%.
Solid balance sheet: No toxic micro-cap debt. With a net debt/EBITDA of ~0.9x and quick/current ratios comfortably above 2.0, the growth phase is fully financed.
Full pipeline: The order backlog was over USD 51 million as at the end of March 2026 - this ensures planning reliability for the coming quarters.
🚀 Growth levers & catalysts:
The Rogoff effect: new CEO Rich Rogoff has been at the helm since April 2026 and delivered straight away at his debut. He has ice-coldly raised the annual forecast for 2026 to USD 130 to 135 million.
Wall Street is waking up: Analysts had to revise their historically depressed share price targets mechanically upwards from USD 10 towards USD 19.30 to USD 20.00 after the Q1 blowout.
Industry diversification: inTEST protects itself from the pure semiconductor hog cycle by aggressively expanding into the thermal test markets of defense/aerospace and medical technology.
⚠️ Valuation & Risks:
The micro-cap whipsaw: with a tiny market capitalization of ~$230m, extreme price volatility and liquidity constraints are commonplace.
Increased working capital requirements: Brutal growth eats up cash. The cash conversion cycle is damn slow at over 100 days because high inventories have to be pre-financed.
The cluster risk: If giants such as Nvidia or AMD consolidate their testing with the industry's billion-dollar giants (Teradyne, Cohu), inTEST will be pushed out of its niche with a cold head.
My conclusion for you: INTT
"Raketentoni, you haven't told a complete fairy tale this time - the Q1 figures prove that the operating leverage at inTEST has just kicked in massively. At a forward P/E of around 18.4x, the speculative growth is absolutely affordable for an AI infrastructure profiteer. But don't make the mistake of confusing this thing with an indestructible moat compounder. It remains a highly cyclical micro-cap gamble for the risk-averse portfolio corner. If you are disciplined and wait for setbacks, you will catch an asymmetrical setup."
Status: 🟢 BUY (as a speculative satellite addition)
Reaper Score: 6/10
•
55
•
@Aktienhauptmeister Your prompt writes almost the same as mine 😁but hey: no fairy tales this time..... I think it's starting 😁😁😁😁
I'm going to put the joint in my portfolio on Side B
I'm going to put the joint in my portfolio on Side B
•
33
•@Raketentoni 🫶🫶 haha, I'm glad to hear that. thanks for the introduction my dear 🚀💪
•
44
•